{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:24:43Z","timestamp":1787963083229,"version":"build-2784847793"},"reference-count":40,"publisher":"American Diabetes Association","issue":"10","license":[{"start":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T00:00:00Z","timestamp":1505865600000},"content-version":"vor","delay-in-days":41,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,10,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>To investigate the association of falling insulin requirements (FIR) among women with preexisting diabetes with adverse obstetric outcomes and maternal biomarkers longitudinally in pregnancy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>A multicenter prospective cohort study of 158 women (41 with type 1 diabetes and 117 with type 2 diabetes) was conducted. Women with FIR of \u226515% from the peak total daily dose after 20 weeks' gestation were considered case subjects (n = 32). The primary outcome was a composite of clinical markers of placental dysfunction (preeclampsia, small for gestational age [\u22645th centile], stillbirth, premature delivery [&amp;lt;30 weeks], and placental abruption). Maternal circulating angiogenic markers (placental growth factor [PlGF] and soluble fms-like tyrosine kinase 1 [sFlt-1]), placental hormones (human placental lactogen, progesterone, and tumor necrosis factor-\u03b1), HbA1c, and creatinine were studied serially during pregnancy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>FIR \u226515% were associated with an increased risk of the composite primary outcome (odds ratio [OR] 4.38 [95% CI 1.9\u201310.3]; P &amp;lt; 0.001), preeclampsia (OR 6.76 [95% CI 2.7\u201316.7]; P &amp;lt; 0.001), and was more common among women with type 1 diabetes (36.6 vs. 14.5%; P = 0.002). Creatinine was modestly elevated among women with FIR \u226515%; however, there was no difference in HbA1c. The ratio of sFlt-1 to PlGF was significantly higher among women with FIR at 25, 30, and 36 weeks, with differences maintained in the subgroup that developed preeclampsia. There was no difference in placental hormones between the groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>This is the first prospective study to associate FIR with altered expression of placental antiangiogenic factors and preeclampsia. FIR are an important clinical sign, among women with preexisting diabetes, that should alert the clinician to investigate underlying placental dysfunction.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc17-0391","type":"journal-article","created":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T00:30:19Z","timestamp":1502411419000},"page":"1323-1330","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":52,"title":["The Association of Falling Insulin Requirements With Maternal Biomarkers and Placental Dysfunction: A Prospective Study of Women With Preexisting Diabetes in Pregnancy"],"prefix":"10.2337","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5418-3699","authenticated-orcid":false,"given":"Suja","family":"Padmanabhan","sequence":"first","affiliation":[{"name":"Diabetes and Endocrinology, Westmead Hospital, Sydney, New South Wales, Australia"},{"name":"Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent W.","family":"Lee","sequence":"additional","affiliation":[{"name":"Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia"},{"name":"Renal Medicine, Westmead Hospital, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Mclean","sequence":"additional","affiliation":[{"name":"Diabetes and Endocrinology, Westmead Hospital, Sydney, New South Wales, Australia"},{"name":"Diabetes and Endocrinology, Blacktown Hospital, Sydney, New South Wales, Australia"},{"name":"Western Sydney University, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Athayde","sequence":"additional","affiliation":[{"name":"Obstetric Medicine, Westmead Hospital, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Lanzarone","sequence":"additional","affiliation":[{"name":"Obstetric Medicine, Nepean Hospital, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qemer","family":"Khoshnow","sequence":"additional","affiliation":[{"name":"Obstetric Medicine, Nepean Hospital, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Peek","sequence":"additional","affiliation":[{"name":"College of Medicine, Biology and Environment, The Australian National University, Canberra, Australian Capital Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Wah","family":"Cheung","sequence":"additional","affiliation":[{"name":"Diabetes and Endocrinology, Westmead Hospital, Sydney, New South Wales, Australia"},{"name":"Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2017,8,10]]},"reference":[{"key":"2022031220072220200_B1","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/ajo.12446","article-title":"Effect of pregnancy on insulin requirements differs between type 1 and type 2 diabetes: A cohort study of 222 pregnancies","volume":"56","author":"Padmanabhan","year":"2016","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"2022031220072220200_B2","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/0002-9343(81)90301-6","article-title":"Effect of euglycemia on the outcome of pregnancy in insulin-dependent diabetic women as compared with normal control subjects","volume":"71","author":"Jovanovic","year":"1981","journal-title":"Am J Med"},{"key":"2022031220072220200_B3","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-66972-9_22","article-title":"Management of maternal diabetes in pregnancy","volume-title":"Carbohydrate Metabolism in Pregnancy and the Newborn","author":"Essex","year":"1979"},{"key":"2022031220072220200_B4","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.2337\/dc14-0506","article-title":"Falling insulin requirements are associated with adverse obstetric outcomes in women with preexisting diabetes","volume":"37","author":"Padmanabhan","year":"2014","journal-title":"Diabetes Care"},{"key":"2022031220072220200_B5","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2337\/diacare.15.10.1323","article-title":"Insulin requirements in insulin-dependent and insulin-requiring GDM women during final month of pregnancy","volume":"15","author":"McManus","year":"1992","journal-title":"Diabetes Care"},{"key":"2022031220072220200_B6","first-page":"253","article-title":"Insulin requirements during pregnancy in women with type I diabetes","volume":"83","author":"Steel","year":"1994","journal-title":"Obstet Gynecol"},{"key":"2022031220072220200_B7","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.diabres.2012.10.013","article-title":"Insulin requirements in late pregnancy in women with type 1 diabetes mellitus: a retrospective review","volume":"98","author":"Achong","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"2022031220072220200_B8","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/pd.4397","article-title":"First-trimester maternal factors and biomarker screening for preeclampsia","volume":"34","author":"Poon","year":"2014","journal-title":"Prenat Diagn"},{"key":"2022031220072220200_B9","doi-asserted-by":"crossref","first-page":"58.e1","DOI":"10.1016\/j.ajog.2011.07.037","article-title":"The sFlt-1\/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients","volume":"206","author":"Verlohren","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"2022031220072220200_B10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N Engl J Med"},{"key":"2022031220072220200_B11","doi-asserted-by":"crossref","first-page":"19009","DOI":"10.3390\/ijms160819009","article-title":"Angiogenesis-related biomarkers (sFlt-1\/PLGF) in the prediction and diagnosis of placental dysfunction: an approach for clinical integration","volume":"16","author":"Herraiz","year":"2015","journal-title":"Int J Mol Sci"},{"key":"2022031220072220200_B12","doi-asserted-by":"crossref","first-page":"676","DOI":"10.2337\/dc10-0719","article-title":"International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy","volume":"33","author":"Metzger","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031220072220200_B13","unstructured":"World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy [article online], 2013. Available from http:\/\/apps.who.int\/iris\/bitstream\/10665\/85975\/1\/WHO_NMH_MND_13.2_eng.pdf. Accessed 22 February 2017"},{"key":"2022031220072220200_B14","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/01.OGX.0000133943.54530.76","article-title":"Pathophysiology of fetal growth restriction: implications for diagnosis and surveillance","volume":"59","author":"Baschat","year":"2004","journal-title":"Obstet Gynecol Surv"},{"key":"2022031220072220200_B15","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.placenta.2008.09.004","article-title":"Screening for placental insufficiency in high-risk pregnancies: is earlier better?","volume":"29","author":"Costa","year":"2008","journal-title":"Placenta"},{"key":"2022031220072220200_B16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.preghy.2014.02.001","article-title":"The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP","volume":"4","author":"Tranquilli","year":"2014","journal-title":"Pregnancy Hypertens"},{"key":"2022031220072220200_B17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/j.semperi.2008.02.002","article-title":"Diagnosis of IUGR: traditional biometry","volume":"32","author":"Platz","year":"2008","journal-title":"Semin Perinatol"},{"key":"2022031220072220200_B18","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.3109\/14767058.2014.880882","article-title":"Discordant clinical presentations of preeclampsia and intrauterine fetal growth restriction with similar pro- and anti-angiogenic profiles","volume":"27","author":"Alahakoon","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2022031220072220200_B19","doi-asserted-by":"crossref","first-page":"F40","DOI":"10.1136\/adc.2005.072264","article-title":"Prenatal predictors of chronic lung disease in very preterm infants","volume":"91","author":"Henderson-Smart","year":"2006","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2022031220072220200_B20","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.2337\/diabetes.51.7.2207","article-title":"TNF-alpha is a predictor of insulin resistance in human pregnancy","volume":"51","author":"Kirwan","year":"2002","journal-title":"Diabetes"},{"key":"2022031220072220200_B21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1210\/jcem-67-2-341","article-title":"Role of gestational hormones in the induction of insulin resistance","volume":"67","author":"Ryan","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031220072220200_B22","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/uog.6244","article-title":"Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia","volume":"32","author":"Akolekar","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2022031220072220200_B23","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","article-title":"Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia","volume":"125","author":"Rana","year":"2012","journal-title":"Circulation"},{"key":"2022031220072220200_B24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11892-015-0579-4","article-title":"Preeclampsia and diabetes","volume":"15","author":"Weissgerber","year":"2015","journal-title":"Curr Diab Rep"},{"key":"2022031220072220200_B25","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.siny.2004.03.006","article-title":"Developmental biology of the placenta and the origins of placental insufficiency","volume":"9","author":"Chaddha","year":"2004","journal-title":"Semin Fetal Neonatal Med"},{"key":"2022031220072220200_B26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1210\/edrv.18.1.0287","article-title":"The biology of vascular endothelial growth factor","volume":"18","author":"Ferrara","year":"1997","journal-title":"Endocr Rev"},{"key":"2022031220072220200_B27","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/HYPERTENSIONAHA.116.06421","article-title":"Angiogenic factors in preeclampsia: from diagnosis to therapy","volume":"67","author":"Karumanchi","year":"2016","journal-title":"Hypertension"},{"key":"2022031220072220200_B28","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/HYPERTENSIONAHA.107.100735","article-title":"Preeclampsia pathogenesis: \u201ctriple a rating\u201d-autoantibodies and antiangiogenic factors","volume":"51","author":"Karumanchi","year":"2008","journal-title":"Hypertension"},{"key":"2022031220072220200_B29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00125-008-1182-x","article-title":"Anti-angiogenic factors and pre-eclampsia in type 1 diabetic women","volume":"52","author":"Yu","year":"2009","journal-title":"Diabetologia"},{"key":"2022031220072220200_B30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/10641955.2013.837175","article-title":"The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes","volume":"33","author":"Cohen","year":"2014","journal-title":"Hypertens Pregnancy"},{"key":"2022031220072220200_B31","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"2022031220072220200_B32","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1681\/ASN.2015020157","article-title":"Removal of soluble Fms-like tyrosine kinase-1 by dextran sulfate apheresis in preeclampsia","volume":"27","author":"Thadhani","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"2022031220072220200_B33","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/HYPERTENSIONAHA.115.06783","article-title":"Placental growth factor administration abolishes placental ischemia-induced hypertension","volume":"67","author":"Spradley","year":"2016","journal-title":"Hypertension"},{"key":"2022031220072220200_B34","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1097\/01.AOG.0000264552.85436.a1","article-title":"Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia","volume":"109","author":"Wikstr\u00f6m","year":"2007","journal-title":"Obstet Gynecol"},{"key":"2022031220072220200_B35","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/pd.4432","article-title":"The relationship of angiogenic factors to maternal and neonatal manifestations of early-onset and late-onset preeclampsia","volume":"34","author":"Pinheiro","year":"2014","journal-title":"Prenat Diagn"},{"key":"2022031220072220200_B36","first-page":"330","article-title":"Human placental lactogen levels and daily insulin requirements in patients with diabetes mellitus complicating pregnancy","volume":"42","author":"Spellacy","year":"1973","journal-title":"Obstet Gynecol"},{"key":"2022031220072220200_B37","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1471-0528.1989.tb02415.x","article-title":"A longitudinal study of circulating progesterone, oestradiol, hCG and hPL during pregnancy in type 1 diabetic mothers","volume":"96","author":"Stewart","year":"1989","journal-title":"Br J Obstet Gynaecol"},{"key":"2022031220072220200_B38","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/2042018813501188","article-title":"Insulin requirements in patients with diabetes and declining kidney function: differences between insulin analogues and human insulin?","volume":"4","author":"Kulozik","year":"2013","journal-title":"Ther Adv Endocrinol Metab"},{"key":"2022031220072220200_B39","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1046\/j.1464-5491.2003.01025.x","article-title":"Decreased insulin requirement in relation to GFR in nephropathic type 1 and insulin-treated type 2 diabetic patients","volume":"20","author":"Biesenbach","year":"2003","journal-title":"Diabet Med"},{"key":"2022031220072220200_B40","unstructured":"Gardosi J, Francis A. A customised Weight Centile Calculator: Gestation Network [Internet], 2013. Available from http:\/\/www.gestation.net\/. Accessed 22 February 2017"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/40\/10\/1323\/547973\/dc170391.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/40\/10\/1323\/547973\/dc170391.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T21:55:40Z","timestamp":1647122140000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/40\/10\/1323\/29609\/The-Association-of-Falling-Insulin-Requirements"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,10]]},"references-count":40,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,8,10]]},"published-print":{"date-parts":[[2017,10,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc17-0391","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,10]]}}}